EP26-A provides users with a protocol to evaluate the consistency of patient sample results when a new analytical reagent lot replaces a reagent lot currently in use. It also helps users detect significant changes in measurement procedure performance for patient samples due to reagent lot changes, and confirms that patient sample results are consistent between two reagent lots.
Read more:
CLSI Published a New Method Evaluation Guideline: EP26-A—User Evaluation of Between-Reagent Lot Variation
Source: CLSI
Image credits: MediaDiagnostici
Art and Science of Laboratory Medicine
Facebook: www.facebook.com/LaboratoryEQAS
Twitter: LaboratoryEQAS
Where on earth has CLSI posted this document? I've been searching everywhere. It seems the only option is to purchase a $170.00 book published by Siemens. Is CLSI becoming a self perpetuating regulatory and money making operation to justify their jobs?
ReplyDeleteI agree that reagent comparison is an important issue and would love some guidance on it. This seems to be a scheme to make money!